Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial

Journal content Created on 09 Jul 2026 Nature Medicine

Published in

Nature Medicine, Nature Publishing Group

Content

There is no additional content. Please click on the source link to view more information.

Liwei Wang

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 34
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement